Natriumoxybat "Ascend" 500 mg/ml oral opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

natriumoxybat "ascend" 500 mg/ml oral opløsning

ascend gmbh - natriumoxybat - oral opløsning - 500 mg/ml

Bluevac BTV (previously known as Bluevac BTV8) Den Europæiske Union - dansk - EMA (European Medicines Agency)

bluevac btv (previously known as bluevac btv8)

cz veterinaria s.a. - bluetongue virus vaccine serotypes 1 or 4 or 8 [inactivated] - immunologiske - sheep; cattle - sheepactive vaccination mod bluetongue virus serotype 8 for at forhindre viraemia og til at reducere kliniske tegn. immunitetens begyndelse: 20 dage efter anden dosis. immunitetens varighed: 1 år efter anden dosis. cattleactive vaccination mod bluetongue virus serotype 8 for at forhindre viraemia. immunitetens begyndelse: 31 dage efter anden dosis. immunitetens varighed: 1 år efter anden dosis.

Felden 0,5% gel Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

felden 0,5% gel

pfizer aps - piroxicam - gel - 0,5%

Hydrocortison med Terramycin 10 + 30 mg/g salve Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

hydrocortison med terramycin 10 + 30 mg/g salve

pfizer aps - hydrocortison, oxytetracyclinhydrochlorid - salve - 10 + 30 mg/g

Hydrocortison m.terramycin+polymyxin-B 15 + 5 + 1 mg/ml øjen- og øredråber, suspension Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

hydrocortison m.terramycin+polymyxin-b 15 + 5 + 1 mg/ml øjen- og øredråber, suspension

pfizer aps - hydrocortisonacetat, oxytetracyclinhydrochlorid, polymyxin b sulfat - øjen- og øredråber, suspension - 15 + 5 + 1 mg/ml

Terramycin-Polymyxin B 5 + 1 mg/g øjensalve Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

terramycin-polymyxin b 5 + 1 mg/g øjensalve

pfizer aps - oxytetracyclinhydrochlorid, polymyxin b sulfat - øjensalve - 5 + 1 mg/g

Terramycin-Polymyxin B 30+1 mg/g salve Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

terramycin-polymyxin b 30+1 mg/g salve

pfizer aps - oxytetracyclinhydrochlorid, polymyxin b sulfat - salve - 30+1 mg/g

Spikevax (previously COVID-19 Vaccine Moderna) Den Europæiske Union - dansk - EMA (European Medicines Agency)

spikevax (previously covid-19 vaccine moderna)

moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older.  spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.

Ebastin "Brown" 10 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

ebastin "brown" 10 mg filmovertrukne tabletter

brown & burk ir limited - ebastin - filmovertrukne tabletter - 10 mg

Ebastin "Brown" 20 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

ebastin "brown" 20 mg filmovertrukne tabletter

brown & burk ir limited - ebastin - filmovertrukne tabletter - 20 mg